Literature DB >> 21749292

An RNA aptamer that selectively recognizes symmetric dimethylation of arginine 8 in the histone H3 N-terminal peptide.

Soonsil Hyun1, Kyung Hyun Lee, Areum Han, Jaehoon Yu.   

Abstract

Epigenetic modifications of N-terminal histone tails, especially histone H3, are important for the regulation of the target genes in chromatin. Specific methods for detection of these modifications in histone H3 N-terminal peptides are valuable tools for diagnostic and therapeutic purposes. As an alternative to antibodies, RNA aptamers display compatible binding affinities and selectivites against various biologically relevant targets. Systematic evolution of ligands by exponential enrichment (SELEX) was performed against histone H3R8Me2sym. A 14-amino acid peptide that mimics this modified histone tail was prepared in a biotinylated form and 10 selection cycles of SELEX were carried out. This produced 4 aptamers, one of which (clone 1) was observed to have low nanomolar binding affinity (K(d)=12 nM) against the cognate peptide. The affinity of this aptamer is comparable to 2 commercially available antibodies against differently modified histone H3 peptides and it displays a greater selectivity than the antibodies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749292     DOI: 10.1089/nat.2011.0300

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  4 in total

Review 1.  Developing epigenetic diagnostics and therapeutics for brain disorders.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Mol Med       Date:  2013-10-18       Impact factor: 11.951

2.  Two helices in the third intracellular loop determine anoctamin 1 (TMEM16A) activation by calcium.

Authors:  Jesun Lee; Jooyoung Jung; Min Ho Tak; Jungwon Wee; Byeongjoon Lee; Yongwoo Jang; Hyeyeon Chun; Dong-Jin Yang; Young Duk Yang; Sang Ho Park; Byung Woo Han; Soonsil Hyun; Jaehoon Yu; Hawon Cho; H Criss Hartzell; Uhtaek Oh
Journal:  Pflugers Arch       Date:  2014-09-19       Impact factor: 3.657

3.  Vasorin is a potential serum biomarker and drug target of hepatocarcinoma screened by subtractive-EMSA-SELEX to clinic patient serum.

Authors:  Shaohua Li; Hui Li; Xiqin Yang; Wei Wang; Aixue Huang; Jie Li; Xingliang Qin; Fei Li; Guanyi Lu; Hongmei Ding; Xueting Su; Lvbin Hou; Wei Xia; Ming Shi; Hongwen Zhang; Qiang Zhao; Jie Dong; Xingfeng Ge; Leqiao Sun; Chenjun Bai; Chaonan Wang; Xuelian Shen; Tao Fang; Fusheng Wang; Heqiu Zhang; Ningsheng Shao
Journal:  Oncotarget       Date:  2015-04-30

Review 4.  Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option.

Authors:  Silvia Catuogno; Carla Lucia Esposito; Paola Ungaro; Vittorio de Franciscis
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.